Provided by Tiger Trade Technology Pte. Ltd.

Xenetic Biosciences Inc

3.59
+0.20005.90%
Post-market: 3.780.1900+5.29%19:19 EDT
Volume:84.26K
Turnover:299.24K
Market Cap:8.41M
PE:-3.02
High:3.73
Open:3.36
Low:3.18
Close:3.39
52wk High:13.93
52wk Low:1.90
Shares:2.34M
Float Shares:1.81M
Volume Ratio:8.97
T/O Rate:4.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1900
EPS(LYR):-1.5800
ROE:-47.04%
ROA:-26.80%
PB:1.39
PE(LYR):-2.27

Loading ...

Company Profile

Company Name:
Xenetic Biosciences Inc
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
2
Office Location:
945 Concord Street,Framingham,Massachusetts,United States
Zip Code:
01701
Fax:
- -
Introduction:
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

Directors

Name
Position
Alexey Vinogradov
Director
Dmitry Genkin
Director
Firdaus Jal Dastoor
Director
Grigory Borisenko
Director
Moshe Mizrahy
Director
Roger Kornberg
Director

Shareholders

Name
Position
James Parslow
Chief Financial Officer and Corporate Secretary and Interim Chief Executive Officer